Sleeve Lobectomy of the Middle Lobe for Hilar Lung Cancer with Accompanying Cardiomyopathy and Actinomycosis

The indication for sleeve lobectomy of the middle lobe is limited, because the frequency of cancer occupying both the middle lobe and its bifurcation is low and the more commonly used middle and lower lobectomy is an alternate procedure. However, if a patient has accompanying cardiopulmonary restriction, lung preservation is paramount. We present a patient with hilar lung cancer (TisN0M0) associated with progressive cardiomyopathy, who underwent sleeve lobectomy of the middle lobe; the cancer took a favorable course.

Key words:

Hilar lung cancer - Sleeve lobectomy of the middle lobe - Cardiomyopathy - Actinomycosis

References

• 1 Watanabe Y, Shimizu J, Oda M. et al . Early hilar lung cancer. Its clinical aspect.  J Surg Oncol.. 1991;  48 75-80
• 2 Wynne J, Braunwald E. The cardiomyopathies and myocarditides. In: Braunwald E, eds. Heart disease, A Textbook of Cardiovascular Medicine. Philadelphia; W.B. Saunders 1997 5th ed: 1404-1463
• 3 Richardson P, McKenna W, Bristow M. et al . Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies.  Circulations.. 1996;  93 841-842
• 4 Maeda M, Nakamoto K, Ohta M. et al . Statistical survey of tracheobronchoplasty in Japan.  Ann Thorac Cardiovasc Surg.. 1988;  97 402-414
• 5 Keller S M, Kaiser L R, Martini N. Bilobectomy for bronchogenic carcinoma.  Ann Thorac Surg.. 1988;  45 62-65
• 6 Slade P R, Slesser B V, Southgate J. Thoracic actinomycusis.  Thorax.. 1973;  28 73-85